TNFSF11 and neoplasm: When abnormally activated, HH signaling is closely linked to tumor development and metastasis [7,8,9], and tumor cell-derived HH signaling can induce receptor activator of nuclear factor-κB ligand (RANKL) production in osteoblasts, stimulating osteoclastogenesis and increasing bone resorption [10].